These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 20142245)
1. Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer. Lönn S; Gilbert ES; Ron E; Smith SA; Stovall M; Curtis RE Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):464-74. PubMed ID: 20142245 [TBL] [Abstract][Full Text] [Related]
2. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. Curtis RE; Boice JD; Stovall M; Bernstein L; Holowaty E; Karjalainen S; Langmark F; Nasca PC; Schwartz AG; Schymura MJ J Natl Cancer Inst; 1994 Sep; 86(17):1315-24. PubMed ID: 8064889 [TBL] [Abstract][Full Text] [Related]
3. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database. Farioli A; Ottone M; Morganti AG; Compagnone G; Romani F; Cammelli S; Mattioli S; Violante FS Cancer Med; 2016 May; 5(5):950-9. PubMed ID: 26860323 [TBL] [Abstract][Full Text] [Related]
4. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Farioli A; Violante FS; Mattioli S; Curti S; Kriebel D Cancer Causes Control; 2013 Aug; 24(8):1535-45. PubMed ID: 23702885 [TBL] [Abstract][Full Text] [Related]
5. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors. Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756 [TBL] [Abstract][Full Text] [Related]
6. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527 [TBL] [Abstract][Full Text] [Related]
7. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Berrington de Gonzalez A; Curtis RE; Kry SF; Gilbert E; Lamart S; Berg CD; Stovall M; Ron E Lancet Oncol; 2011 Apr; 12(4):353-60. PubMed ID: 21454129 [TBL] [Abstract][Full Text] [Related]
8. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293 [TBL] [Abstract][Full Text] [Related]
9. Cancer incidence after localized therapy for prostate cancer. Moon K; Stukenborg GJ; Keim J; Theodorescu D Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323 [TBL] [Abstract][Full Text] [Related]
10. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Berrington de Gonzalez A; Curtis RE; Gilbert E; Berg CD; Smith SA; Stovall M; Ron E Br J Cancer; 2010 Jan; 102(1):220-6. PubMed ID: 19935795 [TBL] [Abstract][Full Text] [Related]
11. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129 [TBL] [Abstract][Full Text] [Related]
12. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908 [TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041 [TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
15. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer. Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P; Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205 [TBL] [Abstract][Full Text] [Related]
16. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy. Abdel-Wahab M; Reis IM; Hamilton K Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503 [TBL] [Abstract][Full Text] [Related]
17. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study. Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104 [TBL] [Abstract][Full Text] [Related]
18. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies. Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519 [TBL] [Abstract][Full Text] [Related]
19. Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers. Ota T; Takeshima N; Tabata T; Hasumi K; Takizawa K Br J Cancer; 2007 Oct; 97(8):1058-62. PubMed ID: 17895888 [TBL] [Abstract][Full Text] [Related]
20. Increased risk of colon cancer after external radiation therapy for prostate cancer. Rapiti E; Fioretta G; Verkooijen HM; Zanetti R; Schmidlin F; Shubert H; Merglen A; Miralbell R; Bouchardy C Int J Cancer; 2008 Sep; 123(5):1141-5. PubMed ID: 18546265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]